Acro Biomedical Co., Ltd.
ACBM· OTC
ACBMAcro Biomedical Co., Ltd.
Source filing unavailable
| Metric | Q4 2018 | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures |
|---|---|---|---|---|
| Revenue | $1.35M | — | — | — |
| Net Income | -$75.02K | $39.50K | -$6.13K | — |
| EPS Diluted | $0.00 | — | — |
Acro Biomedical Co., Ltd. · CIK 1622996 · Engraved from SEC EDGAR
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
